EU set to fine Teva for disparaging rival multiple sclerosis medicine, sources say, ET HealthWorld

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

EU set to fine Teva for disparaging rival multiple sclerosis medicine, sources say, ET HealthWorld

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

London: EU antitrust regulators are set to fine world No. 1 generic drugmaker Teva in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone, people with direct knowledge of the matter said on Tuesday.

The move will come after the ********* Commission charged the ******** company two years ago for breaching EU antitrust rules, saying its anti-competitive behaviour included misusing the patent system to artificially extend Copaxone’s patent.

Companies found guilty of EU antitrust violations risk fines as much as 10% of their global annual turnover, although this is rare. (Reporting by Foo Yun Chee Editing by Mark Potter)

• Published On Sep 11, 2024 at 11:53 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Download ETHealthworld App

• Get Realtime updates
• Save your favourite articles

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Scan to download App
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

This is the hidden content, please

• Sign In
• or
• Sign Up

#set #fine #Teva #disparaging #rival #multiple #sclerosis #medicine #sources #HealthWorld

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up